Spiro Derivatives of Parthenin as Novel Anticancer Agents
申请人:Halmuthur Mahabalarao Sampath Kumar
公开号:US20110201661A1
公开(公告)日:2011-08-18
The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (α-methylene-γ-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 μM to 93 μM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the α,β-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity.
US8609858B2
申请人:——
公开号:US8609858B2
公开(公告)日:2013-12-17
[EN] SPIRO DERIVATIVES OF PARTHENIN AS NOVEL ANTICANCER AGENTS<br/>[FR] DÉRIVÉS SPIRO DE PARTHÉNINE SERVANT DE NOUVEAUX AGENTS ANTICANCÉREUX